Frontiers in Pharmacology,
Journal Year:
2021,
Volume and Issue:
12
Published: Dec. 7, 2021
Gelsemium
elegans
(
G.
)
Benth.,
recognized
as
a
toxic
plant,
has
been
used
traditional
Chinese
medicine
for
the
treatment
of
neuropathic
pain
and
cancer
many
years.
In
present
study,
we
aim
to
obtain
anti-tumor
effects
alkaloids
their
active
components
in
hepatocellular
carcinoma
(HCC)
potential
mechanism
was
also
further
investigated.
We
demonstrated
that
sempervirine
induced
HCC
cells
apoptosis
associated
with
cell
cycle
arrest
during
G
1
phase,
up-regulation
p53
down-regulation
cyclin
D1,
B1
CDK2.
Furthermore,
inhibited
tumor
growth
enhances
effect
sorafenib
vivo
.
addition,
inactivation
Wnt/β-catenin
pathway
found
be
involved
sempervirine-induced
proliferation.
The
study
were
valuable
source
compounds
activity.
Our
findings
justified
compound
proliferation
by
regulating
pathway.
Genes & Diseases,
Journal Year:
2023,
Volume and Issue:
11(2), P. 727 - 746
Published: April 8, 2023
Hepatocellular
carcinoma
(HCC)
is
a
liver
cancer,
highly
heterogeneous
both
at
the
histopathological
and
molecular
levels.
It
arises
from
hepatocytes
as
result
of
accumulation
numerous
genomic
alterations
in
various
signaling
pathways,
including
canonical
WNT/β-catenin,
AKT/mTOR,
MAPK
pathways
well
associated
with
telomere
maintenance,
p53/cell
cycle
regulation,
epigenetic
modifiers,
oxidative
stress.
The
role
WNT/β-catenin
homeostasis
regeneration
established,
whereas
development
progression
HCC
extensively
studied.
Herein,
we
review
recent
advances
our
understanding
how
facilitates
development,
acquisition
stemness
features,
metastasis,
resistance
to
treatment.
We
outline
genetic
that
lead
activated
HCC.
discuss
pivotal
roles
CTNNB1
mutations,
aberrantly
expressed
non-coding
RNAs
complexity
crosstalk
between
other
challenging
or
advantageous
aspects
therapy
stratification
patients
for
Cell Communication and Signaling,
Journal Year:
2025,
Volume and Issue:
23(1)
Published: Jan. 25, 2025
The
hepatocyte
growth
factor
(HGF)
along
with
its
receptor
(c-MET)
are
crucial
in
preserving
standard
cellular
physiological
activities,
and
imbalances
the
c-MET
signaling
pathway
can
lead
to
development
advancement
of
tumors.
It
has
been
extensively
demonstrated
that
immune
checkpoint
inhibitors
(ICIs)
result
prolonged
remission
certain
patients.
Nevertheless,
numerous
preclinical
studies
have
shown
MET
imbalance
hinders
effectiveness
anti-PD-1/PD-L1
treatments
through
various
mechanisms.
Consequently,
clarifying
link
between
tumor
microenvironment
(TME),
as
well
uncovering
effects
anti-MET
treatment
on
ICI
therapy,
is
for
enhancing
outlook
In
this
review,
we
examine
impact
abnormal
activation
HGF/c-MET
control
TME
processes
governing
PD-L1
expression
cancer
cells.
review
thoroughly
examines
both
clinical
practical
evidence
regarding
use
alongside
PD-1/PD-L1
inhibitors,
emphasizing
focusing
immunotherapy
enhances
treating
tumors
exhibiting
elevated
expression.
Cancers,
Journal Year:
2025,
Volume and Issue:
17(3), P. 392 - 392
Published: Jan. 24, 2025
Hepatocellular
carcinoma
(HCC),
the
most
common
form
of
primary
liver
cancer,
is
rising
in
global
incidence
and
mortality.
Metabolic
dysfunction-associated
steatotic
disease
(MASLD),
one
leading
causes
chronic
disease,
strongly
linked
to
metabolic
conditions
that
can
progress
cirrhosis
HCC.
Iron
overload
(IO),
whether
inherited
or
acquired,
results
abnormal
iron
hepatic
deposition,
significantly
impacting
MASLD
development
progression
While
pathophysiological
connections
between
IO,
MASLD,
HCC
are
not
fully
understood,
dysregulation
glucose
lipid
metabolism
IO-induced
oxidative
stress
being
investigated
as
drivers.
Genomic
analyses
IO
reveal
inconsistencies
association
certain
mutations
with
malignancies.
Moreover,
also
associated
hepcidin
activation
ferroptosis,
representing
promising
targets
for
risk
assessment
therapeutic
intervention.
Understanding
relationship
essential
advancing
clinical
strategies
against
progression,
particularly
recent
IO-targeted
therapies
showing
potential
at
improving
biochemistry
insulin
sensitivity.
In
this
review,
we
summarize
current
evidence
on
HCC,
underscoring
importance
early
diagnosis,
stratification,
targeted
treatment
these
interconnected
conditions.
Abstract
Canonical
Wnt/β-catenin
signaling
is
a
complex
cell-communication
mechanism
that
has
central
role
in
the
progression
of
various
cancers.
The
cellular
factors
participate
regulation
this
are
still
not
fully
elucidated.
Lysine
acetylation
significant
protein
modification
which
facilitates
reversible
target
function
dependent
on
activity
lysine
acetyltransferases
(KATs)
and
catalytic
deacetylases
(KDACs).
Protein
been
classified
into
histone
non-histone
acetylation.
Histone
kind
epigenetic
modification,
it
can
modulate
transcription
important
biological
molecules
signaling.
Additionally,
as
type
post-translational
directly
alters
core
Conversely,
regulate
expression
based
or
To
date,
inhibitors
targeting
KATs
KDACs
have
discovered,
some
these
exert
their
anti-tumor
via
blocking
Here,
we
discuss
available
evidence
understanding
complicated
interaction
with
signaling,
new
for
cancer
therapy
controlling
Cancers,
Journal Year:
2023,
Volume and Issue:
15(8), P. 2311 - 2311
Published: April 15, 2023
Recently,
the
therapeutic
combination
of
atezolizumab
and
bevacizumab
was
widely
used
to
treat
advanced
hepatocellular
carcinoma
(HCC).
According
recent
clinical
trials,
immune
checkpoint
inhibitors
(ICIs)
molecular
target
agents
are
expected
be
key
strategies
in
future.
Nonetheless,
mechanisms
underlying
responses
evasion
remain
unclear.
The
tumor
microenvironment
plays
a
vital
role
HCC
progression.
infiltration
CD8-positive
cells
into
tumors
expression
molecules
factors
this
microenvironment.
Specifically,
Wnt/β
catenin
pathway
activation
causes
“immune
exclusion”,
associated
with
poor
cells.
Some
studies
suggested
an
association
between
ICI
resistance
β-catenin
HCC.
Additionally,
several
subclassifications
were
proposed.
can
broadly
divided
inflamed
class
non-inflamed
class,
subclasses.
mutations
important
subclasses;
may
useful
when
considering
as
serve
biomarker
for
ICI.
Various
types
modulators
developed.
Several
kinases
also
involved
pathway.
Therefore,
combinations
modulators,
kinase
inhibitors,
ICIs
exert
synergistic
effects.
Cancers,
Journal Year:
2021,
Volume and Issue:
13(14), P. 3606 - 3606
Published: July 19, 2021
Histone
acetylation
is
generally
associated
with
an
open
chromatin
configuration
that
facilitates
many
cellular
processes
including
gene
transcription,
DNA
repair,
and
replication.
Aberrant
levels
of
histone
lysine
are
the
development
cancer.
Bromodomains
represent
a
family
structurally
well-characterized
effector
domains
recognize
acetylated
lysines
in
chromatin.
As
part
their
fundamental
reader
activity,
bromodomain-containing
proteins
play
versatile
roles
epigenetic
regulation,
additional
functional
modules
often
present
same
protein,
or
through
assembly
larger
enzymatic
complexes.
Dysregulated
expression,
chromosomal
translocations,
and/or
mutations
have
been
correlated
poor
patient
outcomes
Thus,
bromodomains
emerged
as
highly
tractable
class
targets
due
to
well-defined
structural
domains,
increasing
ease
designing
screening
for
molecules
modulate
reading
process.
Recent
developments
pharmacological
agents
target
specific
has
helped
understand
diverse
mechanisms
interaction
partners
variety
processes,
provide
promise
applying
bromodomain
inhibitors
into
clinical
field
cancer
treatment.
In
this
review,
we
explore
expression
protein
interactome
profiles
discuss
them
terms
groups.
Furthermore,
highlight
our
current
understanding
cancer,
well
emerging
strategies
specifically
bromodomains,
combination
therapies
using
alongside
traditional
therapeutic
approaches
designed
re-program
tumorigenesis
metastasis.
Cell Death and Disease,
Journal Year:
2022,
Volume and Issue:
13(5)
Published: May 17, 2022
Circular
RNAs
have
been
reported
to
play
essential
roles
in
the
tumorigenesis
and
progression
of
various
cancers.
However,
biological
processes
mechanisms
involved
hepatocellular
carcinoma
(HCC)
remain
unclear.
Initial
RNA-sequencing
data
qRT-PCR
results
our
cohort
showed
that
hsa_circ_0072309
(also
called
circLIFR)
was
markedly
downregulated
HCC
tissues.
Kaplan-Meier
analysis
indicated
higher
levels
circLIFR
patients
correlated
with
favorable
overall
survival
recurrence-free
rates.
Both
vitro
vivo
experiments
inhibited
proliferation
invasion
abilities
cells.
We
therefore
conducted
related
explore
mechanism
HCC.
Fluorescence
situ
hybridization
revealed
mainly
located
cytoplasm,
RNA
immunoprecipitation
assays
significantly
enriched
by
Ago2
protein.
These
suggested
may
function
as
a
sponge
miRNAs
regulate
progression.
further
bioinformatics
prediction
well
dual-luciferase
reporter
assays,
which
could
miR-624-5p
stabilize
glycogen
synthase
kinase
3β
(GSK-3β)
expression.
Loss
gain
demonstrated
regulation
expression
or
GSK-3β
affected
induced
circLIFR.
Importantly,
we
also
proved
facilitate
degradation
β-catenin
prevent
its
translocation
nucleus
Overall,
study
acts
tumor
suppressor
regulating
inactivating
GSK-3β/β-catenin
signaling
pathway.
Frontiers in Immunology,
Journal Year:
2022,
Volume and Issue:
13
Published: May 20, 2022
The
incidence
of
testicular
germ
cell
tumor
(TGCT)
is
currently
on
the
rise
worldwide,
which
15%-30%
patients
have
occur
recurrence
and
metastasis.
However,
clinical
methods
for
diagnosing
TGCT
judging
its
prognosis
remained
inadequate.
In
this
study,
we
aimed
to
explore
possibility
testis-specific
long-chain
non-coding
RNA
(lncRNA)
Ret
finger
protein-like
3S
(RFPL3S)
as
a
biomarker
diagnosis,
prognosis,
treatment
response
by
reviewing
gene
expression
data
in
Gene
Expression
Omnibus
(GEO)
Cancer
Genome
Atlas
(TCGA)
databases.
cohort
DNA
methylation
TCGA
were
downloaded
from
TGCA,
UCSC
XENA,
GEO.
bioinformatic
tools
used,
including
GEPIA2,
Kaplan-Meier
Plotter,
LinkedOmics,
Sangerbox
Tools,
GSCA,
Tumor
Immune
Dysfunction
Exclusion.
Compared
with
normal
tissues,
RFPL3S
was
significantly
reduced
TGCT,
negatively
correlated
patient’s
Tumor,
Node,
Metastasis
stage.
Hypermethylation
low
copy
number
present
associated
short
disease-free
progression-free
intervals.
Silencing
enhanced
invasion
ability
proliferation
cells
evaluated
Transwell
CCK-8
experiments.
Additionally,
positively
infiltration
immune-activating
such
B
cells,
CD8+
T
cytotoxic
natural
killer
immunosuppressive
Th17
Th2.
Higher
immunotherapy
benefits.
conclusion,
determined
that
lncRNA
functioned
suppressor
could
be
used
prognostic
predictor
well
marker
predict
effect
immunotherapy.